As of May 2025, there have been no new cannabis product recalls or advisories issued in Las Vegas, according to the Nevada Cannabis Compliance Board (CCB). This marks a reassuring trend since the last significant alerts, which stemmed from pesticide and labeling violations in previous years.
Last Alerts: Mislabeled Gummies and Pesticide Concerns
One of the most recent public health notices came in June 2024, when the CCB issued an advisory for Kynd Balance Black Cherry gummies sold at multiple Las Vegas and Henderson dispensaries. While THC levels were accurate, THC‑CBD ratios were mislabeled; gummies listed as 1:1 actually tested at 2:1 THC:CBD. Though not a full recall, consumers were urged to exercise caution, and retailers were required to post advisories and remove affected stock.
Prior to that, in late 2023, the CCB warned against cannabis products treated with “Conserve SC,” an unapproved pesticide, particularly harvests by Redwood Warehouse between September 2023 and August 2024. Again, no recall mandated, but the bulletin led to heightened facility inspections and procedural reviews.
The most concerning recall occurred from mid‑2021 to early 2023, when nearly 8,000 pounds of cannabis and derivatives from Clark Natural Medicinal Solutions were found to contain Ethephon, a plant growth regulator not approved for cannabis use. The CCB issued a public safety bulletin in January 2023, advising dispensaries to pull affected lots and alert consumers.
Industry Reforms Following Recalls
These episodes prompted a regulatory shakeup. Following the Ethephon alert, the CCB intensified mandatory random testing protocols and tightened vendor standards. Pesticide monitoring frequency increased for both flower and infused edibles, and laboratory reporting underwent critical audits to ensure reliable results.
The mislabeled gummy alert led to new labeling accuracy workshops and stricter QC steps at retail level—ensuring dispensaries verify component ratios before sale. Moreover, dispensary staff are now better trained to identify unusual lab results, streamlining internal recall protocols.
Advocacy from industry stakeholders also influenced legislative reform. In April 2025, during a state Senate SB 157 committee hearing, cannabis testing and recall infrastructure took center stage. Representing DigiPath Labs, Todd Denkin emphasized in Nevada’s Assembly Committee that states like California and Colorado have recall portals and public‑alert systems—tools Nevada currently lacks. The hearing underscored the need for Nevada to embed recall safety into its regulatory framework.
Consumer Trust and Forward Momentum
Though no recalls have occurred this year, the regulatory enhancements signal proactive defense. The CCB’s updated testing protocols, combined with clearer lab‑to‑retail chain traceability, suggest Las Vegas’ cannabis industry is maturing.
From unapproved pesticide alerts to mislabeled dosing, each incident has driven policy innovation. Today’s absence of major recalls reflects not just luck, but an industry that learned, evolved and fortified compliance standards—earning consumer trust in a highly regulated market.